FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss

Published on 9 Aug 2023 on Zacks via Yahoo Finance

FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss

Fate Therapeutics FATE reported a loss of 54 cents per share in the second quarter of 2023, narrower than the Zacks Consensus Estimate of a loss of 58 cents and the year-ago loss of 79 cents.

The loss narrowed year over year due to lower R&D expenses.

The company earned collaboration revenues of $0.9 million in the second quarter, which missed the Zacks Consensus Estimate of $7 million and was down from $18.5 million reported in the year-ago quarter.

Read the rest of the article

NASDAQ.FATE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Fate Therapeutics, Inc. (NASDAQ:FATE) Reported Earnings Last Week And Analysts...

Fate Therapeutics, Inc. (NASDAQ:FATE) investors will be delighted, with the company turning in so...

Simply Wall St. · via Yahoo Finance 15 Nov 2024

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2023 Earnings Call Transcript February 26, 2024 Fate The...

Insider Monkey via Yahoo Finance 1 Mar 2024

Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price...

It's been a good week for Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders, because the company...

Simply Wall St. via Yahoo Finance 29 Feb 2024

Fate Therapeutics (FATE) Q4 Earnings Beat, Revenues Fall Y/Y

Fate Therapeutics FATE reported fourth-quarter 2023 loss of 45 cents per share, narrower than the...

Zacks via Yahoo Finance 27 Feb 2024

Domino's To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Agree Realty...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all ana...

Benzinga 27 Feb 2024

Fate Therapeutics Insiders US$207k Short Of Breakeven On Stock Purchase

Insiders who bought US$698.1k worth of Fate Therapeutics, Inc. (NASDAQ:FATE) stock in the last ye...

Simply Wall St. via Yahoo Finance 29 Dec 2023

FATE Q3 Earnings Beat on Lower Expenses, Revenues Fall Y/Y

Fate Therapeutics FATE reported a loss of 46 cents per share in the third quarter of 2023, narrow...

Zacks via Yahoo Finance 9 Nov 2023

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript

Fate Therapeutics, Inc. (NASDAQ:FATE) Q3 2023 Earnings Call Transcript November 8, 2023 Operator:...

Insider Monkey via Yahoo Finance 9 Nov 2023

FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss

Fate Therapeutics FATE reported a loss of 54 cents per share in the second quarter of 2023, narro...

Zacks via Yahoo Finance 9 Aug 2023

One Fate Therapeutics Insider Raised Stake By 83% In Previous Year

Viewing insider transactions for Fate Therapeutics, Inc.'s (NASDAQ:FATE ) over the last year, we ...

Simply Wall St. via Yahoo Finance 22 Jul 2023

News

FATE Q2 Earnings Beat on Lower Expenses, Revenues Miss

NASDAQ.FATE price evolution

Want to become a better investor?